IHD

β-blockers have shown to reduce the rate of CV events in patients with stable CAD.

• YES

• NO

Unlike other beta blockers, bisoprolol have been associated with improvement in insulin sensitivity.

• YES

• NO

β-blockers are not recommended in treating symptoms in patients with Prinzmetal’s angina

• YES

• NO

CCBs are the only anti-anginal that show effect on the long term cardiovascular outcomes

• YES

• NO

GTN has shown antithrombotic and antiplatelet activity.

• YES

• NO

Isosorbide dinitrate has a better side effect profile compared to Isosorbide mononitrate

• YES

• NO

Ivabradine can not be used in combination with β-blockers in patients with high resting heart rates.

• YES

• NO

Ivabradine is the recommended anti-anginal in patients with co-morbid atrial fibrillation

• YES

• NO

Trimetazidine is contraindicated in patients taking PD5i e.g. sildenafil concurrently.

• YES

• NO

Ranolazine is the recommended anti-anginal in stable CAD patient with liver cirrhosis.

• YES

• NO